AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Axogen, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$35.24+0.62 (+1.79%)
Close on Oct 19, 2026
- Market cap
- $1.88B
- P/E (TTM)
- –
- Dividend yield
- –
Axogen statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Axogen | Industry median |
|---|---|---|
| Market Cap | $1.89B | $230.55M |
| Enterprise Value | $1.78B | $202.97M |
| PS Ratio | 7.54 | 3.11 |
| PB Ratio | 7.39 | 3.14 |
| P/TBV Ratio | 7.62 | 4.57 |
| P/FCF Ratio | 220.35 | 27.25 |
| P/OCF Ratio | 125.91 | 22.35 |
Enterprise value
| Measure | Axogen | Industry median |
|---|---|---|
| EV / Sales | 7.10 | 2.92 |
| EV / FCF | 207.39 | 27.85 |
Income (trailing twelve months)
| Measure | Axogen | Industry median |
|---|---|---|
| Revenue | $251.17M | $102.39M |
| Gross Profit | $187.27M | $60.36M |
| Operating Income | -$12.85M | -$4.31M |
| Net Income | -$33.55M | -$6.57M |
| EBITDA | -$6.36M | -$1.98M |
| EPS (Diluted) | -$0.68 | -$0.07 |
Margins
| Measure | Axogen | Industry median |
|---|---|---|
| Gross Margin | 74.6% | 55.1% |
| Operating Margin | -5.12% | -6.04% |
| Profit Margin | -13.4% | -10.5% |
| EBITDA Margin | -2.53% | -2.67% |
| FCF Margin | 3.42% | -0.30% |
Returns
| Measure | Axogen | Industry median |
|---|---|---|
| Return on Equity (ROE) | -18.2% | -19.2% |
| Return on Assets (ROA) | -13.1% | -13.3% |
| Return on Invested Capital (ROIC) | -7.54% | -4.11% |
| Return on Capital Employed (ROCE) | -4.68% | -9.07% |
Growth
| Measure | Axogen | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 23.6% | 8.85% |
| FCF Growth (YoY) | 74.0% | 10.6% |
| Revenue Growth (3Y CAGR) | 17.6% | 7.08% |
| Revenue Growth (5Y CAGR) | 14.9% | 11.8% |
Balance sheet
| Measure | Axogen | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $111.41M | $37.33M |
| Total Debt | $0 | $72.66M |
| Net Cash (Debt) | $111.41M | $3.92M |
| Net Cash Per Share | $2.07 | $0.28 |
| Equity (Book Value) | $256.26M | $57.36M |
| Book Value Per Share | $4.77 | $2.81 |
| Tangible Book Value | $248.69M | $10.71M |
| Working Capital | $170.00M | $54.64M |
Financial position
| Measure | Axogen | Industry median |
|---|---|---|
| Current Ratio | 6.60 | 2.50 |
| Quick Ratio | 4.79 | 1.54 |
| Debt / Equity | 0.00 | 0.38 |
| Debt / FCF | 0.00 | 3.50 |
| Interest Coverage | -3.08 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Axogen | Industry median |
|---|---|---|
| Operating Cash Flow | $15.05M | -$653.46K |
| Capital Expenditures | -$6.45M | -$3.69M |
| Free Cash Flow | $8.60M | -$835.02K |
| FCF Per Share | $0.16 | -$0.02 |
Efficiency
| Measure | Axogen | Industry median |
|---|---|---|
| Asset Turnover | 0.98 | 0.59 |
| Inventory Turnover | 1.52 | 2.21 |
| Revenue Per Employee | $403.82K | $322.57K |
| Profits Per Employee | -$53.94K | -$51.88K |
| Employee Count | 622 | 185 |
Dividends and yields
| Measure | Axogen | Industry median |
|---|---|---|
| Earnings Yield | -1.77% | -6.91% |
| FCF Yield | 0.45% | -0.56% |
Shares
| Measure | Axogen | Industry median |
|---|---|---|
| Shares Outstanding | 53,761,500 | 44,856,700 |
| Shares Change (YoY) | 9.41% | 3.35% |
| Shares Change (QoQ) | 0.95% | 0.27% |
| Float | 49,194,500 | 37,097,900 |
| Shares Held by Insiders | 8.49% | 10.6% |
| Shares Held by Institutions | 100.5% | 63.5% |
Taxes
| Measure | Axogen | Industry median |
|---|---|---|
| Income Tax | $0 | $1.52M |
Scores
| Measure | Axogen | Industry median |
|---|---|---|
| Altman Z-Score | 23.23 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -2.72 | -2.64 |
Calculated by StockData from Axogen's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.